Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 70 | Longs Won 24/70 34% | Profit Factor 0.35 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $2,946.86 |
| Average Win $1,314.69 | Best Trade (Nov 22) $5,083.86 | Sharpe Ratio -130.59 |
| Average Loss -$1,938.62 | Worst Trade (Mar 27) -$13,138.02 | Z-Score -1.35 (82.53%) |
| Commissions $0 | Avg. Trade Length 1m 2w | Expectancy -$823.2 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 22 | 20 | 17 | 15 | 13 | 11 | 9 | 7 | 4 | 2 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ACXP Acurx Pharmaceuticals, Inc. | 36,175.76 | $47,209.36 | $42,376.28 | - | -$4,833.08 | -10.24% | +1.861% |